Stocklytics Platform
Asset logo for symbol AMLX
Amylyx Pharmaceuticals
AMLX61
$3.60arrow_drop_up2.85%$0.10
Penny Stock
Asset logo for symbol AMLX
AMLX61

$3.60

arrow_drop_up2.85%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Amylyx Pharmaceuticals (AMLX) Stocklytics Forecast

According to AI and machine learning algorithms, the stock price of Amylyx Pharmaceuticals, Inc. (AMLX) is projected to experience positive growth in the future. The forecast suggests that the AMLX stock price will continue to rise steadily over the next few years, with a particularly favorable outlook for the year 2023. Analysts have also provided a price target for AMLX, indicating their expectation that the stock will reach a certain value within the designated timeframe. This price target serves as a guide for investors and can influence their decision-making process.
Considering the analyst ratings for Amylyx Pharmaceuticals, Inc. (AMLX) stock, it is important to note that these ratings can vary among different analysts. However, overall, the analyst ratings for AMLX stock have been positive, indicating that it may be a good buy. Investors should carefully consider the forecasts and ratings before making any investment decisions related to AMLX stock.
add Amylyx Pharmaceuticals to watchlist

Keep an eye on Amylyx Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Amylyx Pharmaceuticals (AMLX) stock?

Analysts have set a target price of $43.08 for Amylyx Pharmaceuticals (AMLX), based on forecasts from 24 analysts. The predicted price range extends from a high of $54 to a low of $10. This represents a potential increase of up to 1.4K% and a decrease of 177.78% from the current price of $3.6. These forecasts are as of 2022 Feb 01.
help

What are the analyst ratings for Amylyx Pharmaceuticals (AMLX) stock?

The analyst ratings for Amylyx Pharmaceuticals (AMLX) are distributed as follows: 3 analysts recommend buying, 4 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 7 analysts leans towards a neutral rating. These ratings indicate the general sentiment among the analysts covering Amylyx Pharmaceuticals.
help

What is the AI price prediction for Amylyx Pharmaceuticals (AMLX) stock?

At present, there is no AI or machine-learning-based price prediction available for Amylyx Pharmaceuticals (AMLX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level